H. Khanban, E. Fattahi, and M. Talkhabi, “In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells”, EXCLI J., vol. 18, pp. 300–309, Jun. 2019.